Share on StockTwits

CME Group (NYSE: CME) was the recipient of a ratings changes during the seven days:

  • CME Group had its price target lowered by analysts at UBS AG from $83.00 to $79.00.
  • CME Group had its “equal weight” rating reaffirmed by analysts at Barclays. They now have a $78.00 price target on the stock.
  • CME Group had its “neutral” rating reaffirmed by analysts at Zacks. They now have a $74.00 price target on the stock.
  • CME Group had its price target lowered by analysts at Keefe, Bruyette & Woods from $84.00 to $80.00.
  • CME Group had its “hold” rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a $69.50 price target on the stock, down previously from $76.50.
  • CME Group had its price target lowered by analysts at Jefferies Group from $89.00 to $84.00. They now have a “buy” rating on the stock.

Shares of CME Group Inc (NYSE:CME) opened at 69.59 on Monday. CME Group Inc has a one year low of $62.18 and a one year high of $84.71. The stock’s 50-day moving average is $70.94 and its 200-day moving average is $75.68. The company has a market cap of $23.368 billion and a P/E ratio of 23.06.

CME Group Inc (NYSE:CME) offer a range of global products across all asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.